FDA Approves First Treatment for Ebola
On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…
On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…
Recently Bonum Health announced about their partnership with Singlecare, for prescription saving. On October 13, Trxade Group Inc., an integrated drug procurement, delivery and healthcare…